Digital Harnessing AI to future-proof biopharma The biopharmaceutical industry has crossed the threshold into the AI era.
Digital FDA decision casts doubts over future of psychedelic treatme... Psychedelic therapies have emerged as a promising frontier in mental health treatment, sparking interest from researchers and investors alike.
Digital AI and trusted data: The key to unlocking faster, more cost-... The artificial intelligence (AI) landscape is evolving at a rapid pace.
Digital A journey from personal to public: Digital health passports ... A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Digital Tech & Trials: Can AI save us from drowning in data? Data – it’s everywhere! Especially in clinical trials, where an average trial of about 2,000 patients can expect to produce 3,000,000 points of data.
Digital Sponsored Hyntelo: AI solutions for improved customer engagement Hyntelo, an AI solutions company, specialises in helping pharmaceutical companies leverage data for better customer engagement.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
